[논문]Silibinin Ameliorates O -GlcNAcylation and Inflammation in a Mouse Model of Nonalcoholic Steatohepatitis

Lee, Su Jin; Nam, Min Jung; Lee, Da Eun; Park, Jeen-Woo; Kang, Beom Sik; Lee, Dong-Seok; Lee, Hyun-Shik; Kwon, Oh-Shin

doi:10.3390/ijms19082165

Silibinin Ameliorates O -GlcNAcylation and Inflammation in a Mouse Model of Nonalcoholic Steatohepatitis 원문보기

International journal of molecular sciences, v.19 no.8, 2018년, pp.2165 -

Lee, Su Jin , Nam, Min Jung , Lee, Da Eun , Park, Jeen-Woo , Kang, Beom Sik , Lee, Dong-Seok , Lee, Hyun-Shik , Kwon, Oh-Shin

Abstract ▼ AI-Helper

The mechanisms underlying the progression to non-alcoholic steatohepatitis (NASH) remain to be elucidated. In the present study, we aimed to identify the proteins involved in the pathogenesis of liver tissue inflammation and to investigate the effects of silibinin, a natural polyphenolic flavonoid, on steatohepatitis. We performed comparative proteomic analysis using methionine and choline-deficient (MCD) diet-induced NASH model mice. Eighteen proteins were identified from the two-dimensional proteomic analysis, which are not only differentially expressed, but also significantly improved, by silibinin treatment. Interestingly, seven of these proteins, including keratin cytoskeletal 8 and 18, peroxiredoxin-4, and protein disulfide isomerase, are known to undergo GlcNAcylation modification, most of which are related to structural and stress-related proteins in NASH model animals. Thus, we primarily focused on how the GlcNAc modification of these proteins is involved in the progression to NASH. Remarkably, silibinin treatment alleviates the severity of hepatic inflammation along with O-GlcNAcylation in steatohepatitis. In particular, the reduction of inflammation by silibinin is due to the inhibition of the O-GlcNAcylation-dependent NF-κB-signaling pathway. Therefore, silibinin is a promising therapeutic agent for hyper-O-GlcNAcylation as well as NASH.

주제어

참고문헌 (45)

1. Wong V.W. Chan W.K. Chitturi S. Chawla Y. Dan Y.Y. Duseja A. Fan J. Goh K.L. Hamaguchi M. Hashimoto E. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment J. Gastroenterol. Hepatol. 2018 33 70 85 10.1111/jgh.13857 28670712

상세보기
2. Chitturi S. Wong V.W. Chan W.K. Wong G.L. Wong S.K. Sollano J. Ni Y.H. Liu C.J. Lin Y.C. Lesmana L.A. The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups J. Gastroenterol. Hepatol. 2018 33 86 98 10.1111/jgh.13856 28692197

상세보기
3. Kim J.J. Miura R. Acyl-CoA dehydrogenases and acyl-CoA oxidases. Structural basis for mechanistic similarities and differences Eur. J. Biochem. 2004 271 483 493 10.1046/j.1432-1033.2003.03948.x 14728675

상세보기
4. Pessayre D. Fromenty B. NASH: A mitochondrial disease J. Hepatol. 2005 42 928 940 10.1016/j.jhep.2005.03.004 15885365

상세보기
5. Szabo G. Dolganiuc A. Mandrekar P. Pattern recognition receptors: A contemporary view on liver diseases Hepatology 2006 44 287 298 10.1002/hep.21308 16871558

상세보기
6. Ladas E.J. Cheng B. Hughes D. Kroll D.J. Graf T.N. Oberlies N.H. Rheingold S. Sacks N. Kelly K.M. Milk Thistle is associated with reductions in liver function tests (LFTs) in children undergoing therapy for acute lymphoblastic leukemia (ALL) Blood 2006 108 533a 534a
7. Polyak S.J. Morishima C. Lohmann V. Pal S. Lee D.Y. Liu Y. Graf T.N. Oberlies N.H. Identification of hepatoprotective flavonolignans from silymarin Proc. Natl. Acad. Sci. USA 2010 107 5995 5999 10.1073/pnas.0914009107 20231449

상세보기
8. Saliou C. Valacchi G. Rimbach G. Assessing bioflavonoids as regulators of NF-kappa B activity and inflammatory gene expression in mammalian cells Methods Enzymol. 2001 335 380 387 11400387
9. Abdal Dayem A. Choi H.Y. Yang G.M. Kim K. Saha S.K. Cho S.G. The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms Nutrients 2016 8 581 10.3390/nu8090581 27657126

상세보기
10. Buse M.G. Robinson K.A. Marshall B.A. Hresko R.C. Mueckler M.M. Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles Am. J. Physiol.-Endocrinol. Metab. 2002 283 E241 E250 10.1152/ajpendo.00060.2002 12110528

상세보기
11. Peterson S.B. Hart G.W. New insights: A role for O-GlcNAcylation in diabetic complications Crit. Rev. Biochem. Mol. Biol. 2016 51 150 161 10.3109/10409238.2015.1135102 26806492

상세보기
12. Slawson C. Copeland R.J. Hart G.W. O-GIcNAc signaling: A metabolic link between diabetes and cancer? Trends Biochem. Sci. 2010 35 547 555 10.1016/j.tibs.2010.04.005 20466550

상세보기
13. Zeidan Q. Hart G.W. The intersections between O-GlcNAcylation and phosphorylation: Implications for multiple signaling pathways J. Cell Sci. 2010 123 13 22 10.1242/jcs.053678 20016062

상세보기
14. Hart G.W. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins Annu. Rev. Biochem. 1997 66 315 335 10.1146/annurev.biochem.66.1.315 9242909

상세보기
15. Van Herck M.A. Vonghia L. Francque S.M. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide Nutrients 2017 9 1072 10.3390/nu9101072 28953222

상세보기
16. Rolo A.P. Teodoro J.S. Palmeira C.M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis Free Radical Biol. Med. 2012 52 59 69 10.1016/j.freeradbiomed.2011.10.003 22064361

상세보기
17. Kang J.H. Ryu H.S. Kim H.T. Lee S.J. Choi U.K. Park Y.B. Huh T.L. Choi M.S. Kang T.C. Choi S.Y. Proteomic analysis of human macrophages exposed to hypochlorite-oxidized low-density lipoprotein Biochim. Biophys. Acta 2009 1794 446 458 10.1016/j.bbapap.2008.11.015 19103313

상세보기
18. Kang J.H. Cho H.J. Lee I.S. Kim M. Lee I.K. Chang Y.C. Comparative proteome analysis of TGF-beta1-induced fibrosis processes in normal rat kidney interstitial fibroblast cells in response to ascofuranone Proteomics 2009 9 4445 4456 10.1002/pmic.200800941 19688726

상세보기
19. Lee S.J. Kang J.H. Choi S.Y. Suk K.T. Kim D.J. Kwon O.S. PKC delta as a Regulator for TGF beta 1-Induced alpha-SMA Production in a Murine Nonalcoholic Steatohepatitis Model PLoS ONE 2013 8 e55979 23441159
20. Rinella M.E. Green R.M. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance J. Hepatol. 2004 40 47 51 10.1016/j.jhep.2003.09.020 14672613

상세보기
21. De Souza C.O. Peracoli M.T.S. Weel I.C. Bannwart C.F. Romao M. Nakaira-Takahagi E. de Medeiros L.T.L. da Silva M.G. Peracoli J.C. Hepatoprotective and anti-inflammatory effects of silibinin on experimental preeclampsia induced by 1-NAME in rats Life Sci. 2012 91 159 165 10.1016/j.lfs.2012.06.036 22781706

상세보기
22. Agarwal C. Wadhwa R. Deep G. Biedermann D. Gazak R. Kren V. Agarwal R. Anti-Cancer Efficacy of Silybin Derivatives—A Structure-Activity Relationship PLoS ONE 2013 8 e60074 10.1371/journal.pone.0060074 23555889

상세보기
23. Yoshida H. Matsui T. Yamamoto A. Okada T. Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor Cell 2001 107 881 891 10.1016/S0092-8674(01)00611-0 11779464

상세보기
24. Chaiyawat P. Netsirisawan P. Svasti J. Champattanachai V. Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer Front. Endocrinol. (Lausanne) 2014 5 193 10.3389/fendo.2014.00193 25426101

상세보기
25. Baldini S.F. Lefebvre T. O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes Front. Oncol. 2016 6 6 10.3389/fonc.2016.00006 26835421

상세보기
26. Baudoin L. Issad T. O-GlcNAcylation and inflammation: A vast territory to explore Front. Endocrinol. 2015 5 235 10.3389/fendo.2014.00235 25620956

상세보기
27. Ma J.F. Hart G.W. Protein O-GlcNAcylation in diabetes and diabetic complications Expert Rev. Proteom. 2013 10 365 380 10.1586/14789450.2013.820536 23992419

상세보기
28. Visinoni S. Khalid N.F.I. Joannides C.N. Shulkes A. Yim M. Whitehead J. Tiganis T. Lamont B.J. Favaloro J.M. Proietto J. The Role of Liver Fructose-1,6-Bisphosphatase in Regulating Appetite and Adiposity Diabetes 2012 61 1122 1132 10.2337/db11-1511 22517657

상세보기
29. Makino T. Yamasaki M. Takeno A. Shirakawa M. Miyata H. Takiguchi S. Nakajima K. Fujiwara Y. Nishida T. Matsuura N. Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus Br. J. Cancer 2009 101 1298 306 10.1038/sj.bjc.6605313 19755983

상세보기
30. Schussler M.H. Skoudy A. Ramaekers F. Real F.X. Intermediate Filaments as Differentiation Markers of Normal Pancreas and Pancreas Cancer Am. J. Pathol. 1992 140 559 568 1372155

상세보기
31. Chou C.F. Smith A.J. Omary M.B. Characterization and Dynamics of O-Linked Glycosylation of Human Cytokeratin-8 and Cytokeratin-18 J. Biol. Chem. 1992 267 3901 3906 1371281
32. Ku N.O. Omary M.B. Identification and Mutational Analysis of the Glycosylation Sites of Human Keratin-18 J. Biol. Chem. 1995 270 11820 11827 10.1074/jbc.270.20.11820 7538124

상세보기
33. Srikanth B. Vaidya M.M. Kalraiya R.D. O-GlcNAcylation Determines the Solubility, Filament Organization, and Stability of Keratins 8 and 18 J. Biol. Chem. 2010 285 34062 34071 10.1074/jbc.M109.098996 20729549

상세보기
34. Okado-Matsumoto A. Matsumoto A. Fujii J. Taniguchi N. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions FASEB J. 2000 14 493 501 10.1093/oxfordjournals.jbchem.a022632

상세보기
35. Fujii J. Tsunoda S. Redox regulation of fertilisation and the spermatogenic process Asian J. Androl. 2011 13 420 423 10.1038/aja.2011.10 21460861

상세보기
36. Iuchi Y. Okada F. Tsunoda S. Kibe N. Shirasawa N. Ikawa M. Okabe M. Ikeda Y. Fujii J. Peroxiredoxin 4 knockout results in elevated spermatogenic cell death via oxidative stress Biochem. J. 2009 419 149 158 10.1042/BJ20081526 19105792

상세보기
37. Galligan J.J. Petersen D.R. The human protein disulfide isomerase gene family Hum. Genom. 2012 6 6 10.1186/1479-7364-6-6 23245351

상세보기
38. Zhang X.Q. Yang J.T. Guo Y.B. Ye H. Yu C.H. Xu C.F. Xu L. Wu S.F. Sun W. Wei H.D. Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-Coenzyme A Hydratase Down-Regulation Exacerbates Hepatic Steatosis Hepatology 2010 51 1190 1199 10.1002/hep.23486 20162621

상세보기
39. Greten F.R. Arkan M.C. Bollrath J. Hsu L.C. Goode J. Miething C. Goktuna S.I. Neuenhahn M. Fierer J. Paxian S. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta Cell 2007 130 918 931 10.1016/j.cell.2007.07.009 17803913

상세보기
40. Karin M. NF-kappa B as a Critical Link between Inflammation and Cancer Cold Spring Harb Perspect. Biol. 2009 1 a000141 10.1101/cshperspect.a000141 20066113

상세보기
41. Karin M. Lawrence T. Nizet V. Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer Cell 2006 124 823 835 10.1016/j.cell.2006.02.016 16497591

상세보기
42. MacMicking J.D. Nathan C. Hom G. Chartrain N. Fletcher D.S. Trumbauer M. Stevens K. Xie Q.W. Sokol K. Hutchinson N. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase Cell 1995 81 641 650 10.1016/0092-8674(95)90085-3 7538909

상세보기
43. James L.R. Tang D. Ingram A. Ly H. Thai K. Cai L. Scholey J.W. Flux through the hexosamine pathway is a determinant of nuclear factor kappa B-dependent promoter activation Diabetes 2002 51 1146 1156 10.2337/diabetes.51.4.1146 11916938

상세보기
44. Yang W.H. Park S.Y. Nam H.W. Kim D.H. Kang J.G. Kang E.S. Kim Y.S. Lee H.C. Kim K.S. Cho J.W. NF kappa B activation is associated with its O-GlcNAcylation state under hyperglycemic conditions Proc. Natl. Acad. Sci. USA 2008 105 17345 17350 10.1073/pnas.0806198105 18988733

상세보기
45. Ramakrishnan P. Clark P.M. Mason D.E. Peters E.C. Hsieh-Wilson L.C. Baltimore D. Activation of the transcriptional function of the NF-kappaB protein c-Rel by O-GlcNAc glycosylation Sci. Signal. 2013 6 ra75 10.1126/scisignal.2004097 23982206

상세보기

LOADING...

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Silibinin Ameliorates O -GlcNAcylation and Inflammation in a Mouse Model of Nonalcoholic Steatohepatitis 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (45)

이 논문을 인용한 문헌

연구과제 타임라인

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트

연합인증

Silibinin Ameliorates O -GlcNAcylation and Inflammation in a Mouse Model of Nonalcoholic Steatohepatitis 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (45)

이 논문을 인용한 문헌

연구과제 타임라인

전체(0) 논문(0) 특허(0) 보고서(0)

전체(0) 논문(0) 특허(0) 보고서(0)

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트